1 |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2 |
DESAI K, MCMANUS J M, SHARIFI N. Hormonal therapy for prostate cancer[J]. Endocr Rev, 2021, 42(3): 354-373.
|
3 |
ROSSI M, BUCCI G, RIZZOTTO D, et al. LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β[J]. Nat Commun, 2019, 10(1): 1969.
|
4 |
YUAN H H, DENG R, ZHAO X, et al. SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis[J]. Mol Cancer, 2017, 16(1): 157.
|
5 |
LU W M, WANG Q, XU C, et al. SUMOylation is essential for Sirt2 tumor-suppressor function in neuroblastoma[J]. Neoplasia, 2021, 23(1): 129-139.
|
6 |
WANG T T, ABOU-OUF H, HEGAZY S A, et al. Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients[J]. J Mol Med, 2016, 94(12): 1411-1422.
|
7 |
POLKINGHORN W R, PARKER J S, LEE M X, et al. Androgen receptor signaling regulates DNA repair in prostate cancers[J]. Cancer Discov, 2013, 3(11): 1245-1253.
|
8 |
CHENG C, CAI Y X, LIU X W, et al. KHSRP modulated cell proliferation and cell cycle via regulating PPP2CA and p27 expression in Wilms tumor[J]. Cell Signal, 2022, 100: 110447.
|
9 |
XU J Y, WANG D S, MA H L, et al. KHSRP combines transcriptional and posttranscriptional mechanisms to regulate monocytic differentiation[J]. Blood Sci, 2022, 4(3): 103-115.
|
10 |
RAMDZAN Z M, NEPVEU A. CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers[J]. Nat Rev Cancer, 2014, 14: 673-682.
|
11 |
REBELLO R J, OING C, KNUDSEN K E, et al. Prostate cancer[J]. Nat Rev Dis Primers, 2021, 7: 9.
|
12 |
NARITA S, NOMURA K, HATAKEYAMA S, et al. Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer[J]. Sci Rep, 2019, 9(1): 12071.
|
13 |
LABAF M, LI M Q, TING L, et al. Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2[J]. Front Oncol, 2022, 12: 1021845.
|
14 |
KUROZUMI S, JOSEPH C, RAAFAT S, et al. Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer[J]. Breast Cancer Res Treat, 2019, 176(1): 63-73.
|